CT
IBB icon

CMT Trading’s iShares Biotechnology ETF IBB Stock Holding History

CMT Trading’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,778
Closed -$287K – 26
2017
Q2 		$287K Sell
2,778
-2,910
-51% -$287K 0.58% 20
2017
Q1 		$556K Buy
5,688
+2,241
+65% +$215K 0.77% 18
2016
Q4 		$305K Buy
+3,447
New +$314K 0.37% 21

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CMT Trading's IBB Position: Q3 2017 in Review

CMT Trading sold out of iShares Biotechnology ETF (IBB) in Q3 2017, closing a stake of 2,778 shares — an estimated $287K sold.

CMT Trading first reported a position in IBB in Q4 2016 and held it in 3 quarters. The position peaked at $556K in Q1 2017. 583 funds tracked by Wall St. Rank hold IBB as of Q3 2017.

  • CMT Trading reported no remaining iShares Biotechnology ETF position as of Q3 2017 after selling out during the quarter.
  • CMT Trading sold 2,778 iShares Biotechnology ETF shares in Q3 2017, an estimated $287K.
  • CMT Trading first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 3 quarters.
  • CMT Trading's iShares Biotechnology ETF position peaked at $556K in Q1 2017.
  • 583 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2017.

Based on CMT Trading's 13F filing for Q3 2017, filed 14 Nov 2017.